ARWR

ARROWHEAD PHARMACEUTICALS, INC.

ARWR · CIK 879407 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$829M
20182025
Net Income−$2M
20182025
Operating CF$180M
20182025
Free Cash Flow$157M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.8B$0.0B$0.2B$0.2B$0.1B$0.0B$0.0B$0.0B
Cost of Revenue————————
Gross Profit————————
R&D Expense$0.6B———————
SG&A Expense————————
Operating Income$0.1B$-0.6B$-0.2B$-0.2B$-0.1B$-0.1B$0.0B$-0.0B
Net Income$-0.0B$-0.6B$-0.2B$-0.2B$-0.1B$-0.1B$0.1B$-0.0B
EPS (Basic)$-0.01$-5.00$-1.92$-1.67$-1.36$-0.48$0.12—
EPS (Diluted)$-0.01$-5.00$-1.92$-1.67$-1.36$-0.48$0.12—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.4B$1.1B$0.8B$0.7B$0.7B$0.5B$0.3B$0.1B
Current Assets$1.0B$0.7B$0.4B$0.4B$0.4B$0.3B$0.3B$0.1B
Cash & Equivalents————$0.2B$0.1B$0.2B$0.0B
Total Liabilities————————
Current Liabilities$0.2B$0.1B$0.1B$0.1B$0.1B$0.0B$0.1B$0.0B
Stockholders' Equity$0.5B$0.2B$0.3B$0.4B—$0.5B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.2B$-0.5B$-0.2B$-0.1B$0.2B$-0.1B$0.2B$-0.0B
Investing Cash Flow$-0.1B$-0.4B$-0.1B$-0.0B$-0.1B$-0.2B$-0.0B$-0.0B
Capital Expenditures$0.0B$0.1B$0.2B$0.1B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.1B$0.9B$0.3B$0.1B$0.0B$0.3B$0.1B$0.1B
← Companies